« Previous
Next »
Titles
- Parents with low incomes faced greater health challenges and problems accessing and affording needed health care in Spring 20211
- Parents’ intentions to vaccinate children for COVID-19 by child age: sociodemographic factors and reasons for hesitancy1
- Part D plans generally include drugs commonly used by dual eligibles: 20221
- Participation: who are the eligible but unenrolled?1
- Partners in vaccination: promoting COVID-19 vaccination for medically fragile adults1
- Patient engagement in the design and conduct of medical device clinical studies: guidance for industry, Food and Drug Administration staff, and other stakeholders1
- Patients diagnosed with post-COVID conditions: an analysis of private healthcare claims using the official ICD-10 diagnostic code1
- Payment reform1
- Pharmacokinetic-based criteria for supporting alternative dosing regimens of programmed cell death receptor-1 (PD-1) or programmed cell death-ligand 1 (PD-L1) blocking antibodies for treatment of patients with cancer: guidance for industry1
- Plain and clear: making Medi-Cal communications easy to understand1
- Policy approaches to reduce what commercial health insurers pay for hospitals’ and physicians’ services1
- Policy approaches to reduce what commercial insurers pay for hospitals’ and physicians’ services1
- Policy for monkeypox tests to address the public health emergency: guidance for laboratories, commercial manufacturers, and Food and Drug Administration staff1
- Policy recommendations to grow EHS-CCP in states1
- Policy regarding N-acetyl-L-cysteine: guidance for industry1
- Population pharmacokinetics1
- Postmarket surveillance under section 522 of the Federal Food, Drug, and Cosmetic Act: guidance for industry and Food and Drug Administration staff1
- Pre-Launch Activities Importation Requests (PLAIR)1
- Preparing for the biggest coverage event since the Affordable Care Act: perspectives from state health officials on the end of Medicaid’s continuous coverage requirement1
- Prescription drugs: spending, use, and prices1